Filing step-change
ELIXIR · 2026-08
Quarterly observations that moved versus the prior period in 2026-08. Facts only — not a call to act.
Narrative date 2026-08-31 · Evidence medium
ELIXIR Sees Significant Improvement in Gross Margin and Marginal Operating Leverage, Despite Decelerating Revenue Growth and Revenue Growth Yoy.
Raw Evidence
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 99.46 % | 60.99 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 60.99 % | 15.21 | ▲ |
| REVENUE_GROWTH_YOY | 73.9 % | 124.7 | ▼ |
Cite this
Source: Samhati filing step-change for ELIXIR (2026-08). Observation: ELIXIR Sees Significant Improvement in Gross Margin and Marginal Operating Leverage, Despite Decelerating Revenue Growth and Revenue Growth Yoy. Evidence quality: medium. Not investment advice — no buy, sell, or hold recommendation. Full narrative (Pro): https://samhati.ai/pricing Page: https://samhati.ai/stock/elixir/q/2026-08
Other periods